Page last updated: 2024-10-30

metformin and HELLP Syndrome

metformin has been researched along with HELLP Syndrome in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

HELLP Syndrome: A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count (THROMBOCYTOPENIA). HELLP syndrome is observed in pregnant women with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glueck, CJ1
Bornovali, S1
Pranikoff, J1
Goldenberg, N1
Dharashivkar, S1
Wang, P1

Other Studies

1 other study available for metformin and HELLP Syndrome

ArticleYear
Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
    Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:8

    Topics: Adult; Birth Weight; Body Weight; Diabetes, Gestational; Female; Gestational Age; HELLP Syndrome; Hu

2004